Grifols | GRFS - Cost Of Sales

Stock Price
8.98
Daily Change
0.02 0.22%
Monthly
-2.29%
Yearly
6.40%
Q1 Forecast
9.14

Grifols reported EUR1.32B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
aTyr Pharma USD 22.13M 6.75M Sep/2025
Cara Therapeutics USD 0 0 Mar/2025
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Grifols EUR 1.32B 22.75M Sep/2025
Infinity Pharmaceuticals USD 352K 89K Jun/2023
Minerva Neurosciences 386K 31K Jun/2024
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Sangamo BioSciences 2.42M 1.11M Jun/2024
TherapeuticsMD USD -11.99M 12.34M Dec/2022